UK Biotech Closes €50M Series A for GPCR Drug Discovery
Oxford-based OMass Therapeutics has extended its Series A round by €33M to fund the spectrometry-assisted…
17/02/2020 - 2 minutes
Oxford-based OMass Therapeutics has extended its Series A round by €33M to fund the spectrometry-assisted…
MiroBio has spun out of the University of Oxford with a Series A round of…
Evotec and the University of Oxford have announced the academic projects that will receive a…
The German CRO has struck a deal with the University of Oxford to test a…
OxStem's strategy for stem cells therapy inside the body could have a big impact in…
As we already well know, Neil Woodford is an Economist investor listed as one of…
Cash is floating into Biotech like never before, in the US as well as in…